An escherichia coli engineering bacterium for producing batroxobin with controllable generation and a construction method and application thereof
By constructing a hokC toxin protein expression vector and combining it with the constitutive promoter trxA fragment, the problem of imprecise control of hirudin production in engineered Escherichia coli strains was solved. Active response and production regulation were achieved under conditions without inducers, making it applicable to a variety of hirudin-synthesizing strains and meeting the production needs of the biopharmaceutical field.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- INST OF BOTANY JIANGSU PROVINCE & CHINESE ACADEMY OF SCI
- Filing Date
- 2026-03-11
- Publication Date
- 2026-07-14
AI Technical Summary
In existing technologies, the production control of engineered hirudin-producing Escherichia coli is not precise enough, making it difficult to actively respond without inducers. Furthermore, leaked engineered bacteria may survive and spread for a long time, affecting the safety and efficiency of industrial production.
The hokC toxin expression vector pET28a(+)-ptrxA-hokC was constructed and transformed into a hirudin-producing strain. The hirudin-producing Escherichia coli strain was constructed by regulating the hirudin production through the constitutive promoter trxA fragment. The hirudin production was finely regulated through multiple rounds of culture.
It achieves active response and precise control of hirudin production under inducer-free conditions, enhances the convenience and autonomy of regulation, adapts to industrial production needs, is applicable to a variety of hirudin-synthesizing strains, and has versatility.
Smart Images

Figure CN121826015B_ABST